UNSPSC 51112527: Sarcolysin hydrochloride

This classification denotes a nitrogen mustard compound with the molecular formula C13H18Cl2N2O2.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier GEG3Q4FC64, chemically known as alanine, 3-(p-(bis(2-chloroethyl)amino)phenyl)-, monohydrochloride, dl-, but more generally known as sarcolysin hydrochloride, which bears US NIH Compound Identifier 4053. European Medicines Agency schedules sarcolysin hydrochloride or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10448MIG.

Most nations, for tariff purposes, schedule sarcolysin hydrochloride under HS 29224995. SMILES: C1CC(CCC1CC(C(=O)O)N)N(CCCL)CCCL.CL.

UNSPSC 51112527 Sarcolysin hydrochloride is a Commodity code for a specific pharmaceutical agent used in cancer treatment. State and local government procurement under this code centers on the acquisition of sarcolysin hydrochloride itself — a chemotherapy drug approved for use in multiple myeloma and other malignancies — typically through health departments, correctional health systems, state Medicaid programs, hospital networks, and cancer treatment centers that serve public populations. The drug is sourced either directly from manufacturers or through group purchasing organizations and cooperative contracts that state health agencies and regional hospital systems use to manage oncology pharmaceutical costs.

The provided source contains no recent state or local solicitation records for sarcolysin hydrochloride, preventing characterization of current geographic activity, issuing-body distribution, or representative recent opportunities under this code.